Clinical Trial Update: Study Evaluating Efficacy / Safety of Etanercept + Methotrexate Compared to Usual Treatment in Moderate RA Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating the efficacy and safety of Etanercept plus Methotrexate versus usual treatment in moderate rheumatoid arthritis was terminated, with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Etanercept (etanercept)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED | Results posted: 2011-01-10